309 related articles for article (PubMed ID: 9721026)
1. Comparison of metoprolol and carvedilol pharmacology and cardioprotection in rabbit ischemia and reperfusion model.
Feuerstein G; Liu GL; Yue TL; Cheng HY; Hieble JP; Arch JR; Ruffolo RR; Ma XL
Eur J Pharmacol; 1998 Jun; 351(3):341-50. PubMed ID: 9721026
[TBL] [Abstract][Full Text] [Related]
2. Comparison of bisoprolol and carvedilol cardioprotection in a rabbit ischemia and reperfusion model.
Gao F; Chen J; Lopez BL; Christopher TA; Gu J; Lysko P; Ruffolo RR; Ohlstein EH; Ma XL; Yue TL
Eur J Pharmacol; 2000 Oct; 406(1):109-16. PubMed ID: 11011041
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of carvedilol and metoprolol on cardiac ischemia-reperfusion injury.
Khandoudi N; Percevault-Albadine J; Bril A
J Cardiovasc Pharmacol; 1998 Sep; 32(3):443-51. PubMed ID: 9733358
[TBL] [Abstract][Full Text] [Related]
4. Cardioprotective effects of carvedilol, a novel beta adrenoceptor antagonist with vasodilating properties, in anaesthetised minipigs: comparison with propranolol.
Bril A; Slivjak M; DiMartino MJ; Feuerstein GZ; Linee P; Poyser RH; Ruffolo RR; Smith EF
Cardiovasc Res; 1992 May; 26(5):518-25. PubMed ID: 1359930
[TBL] [Abstract][Full Text] [Related]
5. Carvedilol, a new beta adrenoreceptor blocker and free radical scavenger, attenuates myocardial ischemia-reperfusion injury in hypercholesterolemic rabbits.
Ma XL; Yue TL; Lopez BL; Barone FC; Christopher TA; Ruffolo RR; Feuerstein GZ
J Pharmacol Exp Ther; 1996 Apr; 277(1):128-36. PubMed ID: 8613909
[TBL] [Abstract][Full Text] [Related]
6. Different effects of carvedilol, metoprolol, and propranolol on left ventricular remodeling after coronary stenosis or after permanent coronary occlusion in rats.
Yaoita H; Sakabe A; Maehara K; Maruyama Y
Circulation; 2002 Feb; 105(8):975-80. PubMed ID: 11864928
[TBL] [Abstract][Full Text] [Related]
7. Comparison of pharmacodynamics between carvedilol and metoprolol in rats with isoproterenol-induced cardiac hypertrophy: effects of carvedilol enantiomers.
Hanada K; Asari K; Saito M; Kawana J; Mita M; Ogata H
Eur J Pharmacol; 2008 Jul; 589(1-3):194-200. PubMed ID: 18534575
[TBL] [Abstract][Full Text] [Related]
8. SB 211475, a metabolite of carvedilol, reduces infarct size after myocardial ischemic and reperfusion injury in rabbits.
Brunvand H; Liu G; Ma XL; Yue TL; Ruffolo RR; Feuerstein GZ
Eur J Pharmacol; 1998 Sep; 356(2-3):193-8. PubMed ID: 9774249
[TBL] [Abstract][Full Text] [Related]
9. Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol.
Yue TL; Ma XL; Wang X; Romanic AM; Liu GL; Louden C; Gu JL; Kumar S; Poste G; Ruffolo RR; Feuerstein GZ
Circ Res; 1998 Feb; 82(2):166-74. PubMed ID: 9468187
[TBL] [Abstract][Full Text] [Related]
10. Cardioprotective effects of carvedilol on acute autoimmune myocarditis: anti-inflammatory effects associated with antioxidant property.
Yuan Z; Shioji K; Kihara Y; Takenaka H; Onozawa Y; Kishimoto C
Am J Physiol Heart Circ Physiol; 2004 Jan; 286(1):H83-90. PubMed ID: 14684360
[TBL] [Abstract][Full Text] [Related]
11. Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity.
Feuerstein GZ; Yue TL; Cheng HY; Ruffolo RR
J Hypertens Suppl; 1993 Jun; 11(4):S41-8. PubMed ID: 8104241
[TBL] [Abstract][Full Text] [Related]
12. Carvedilol inhibits activation of stress-activated protein kinase and reduces reperfusion injury in perfused rabbit heart.
Yue TL; Ma XL; Gu JL; Ruffolo RR; Feuerstein GZ
Eur J Pharmacol; 1998 Mar; 345(1):61-5. PubMed ID: 9593595
[TBL] [Abstract][Full Text] [Related]
13. Nebivolol, bucindolol, metoprolol and carvedilol are devoid of intrinsic sympathomimetic activity in human myocardium.
Brixius K; Bundkirchen A; Bölck B; Mehlhorn U; Schwinger RH
Br J Pharmacol; 2001 Aug; 133(8):1330-8. PubMed ID: 11498519
[TBL] [Abstract][Full Text] [Related]
14. Carvedilol versus metoprolol in the acute phase of myocardial infarction:
Bonnemeier H; Ortak J; Tölg R; Witt M; Schmidt J; Wiegand UK; Bode F; Schunkert H; Richardt G
Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S222-6. PubMed ID: 15683501
[TBL] [Abstract][Full Text] [Related]
15. Effect of beta-blockers on beta3-adrenoceptor expression in chronic heart failure.
Zhao Q; Wu TG; Jiang ZF; Chen GW; Lin Y; Wang LX
Cardiovasc Drugs Ther; 2007 Apr; 21(2):85-90. PubMed ID: 17440824
[TBL] [Abstract][Full Text] [Related]
16. Myocardial protection with carvedilol.
Feuerstein GZ; Hamburger SA; Smith EF; Bril A; Ruffolo RR
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S138-41. PubMed ID: 1378142
[TBL] [Abstract][Full Text] [Related]
17. Cardioprotective effects of the vasodilator/beta-adrenoceptor blocker, carvedilol, in two models of myocardial infarction in the rat.
Smith EF; Griswold DE; Hillegass LM; Slivjak MJ; Davis PA; DiMartino MJ
Pharmacology; 1992; 44(6):297-305. PubMed ID: 1354874
[TBL] [Abstract][Full Text] [Related]
18. A comparison of carvedilol and metoprolol antioxidant activities in vitro.
Lysko PG; Webb CL; Gu JL; Ohlstein EH; Ruffolo RR; Yue TL
J Cardiovasc Pharmacol; 2000 Aug; 36(2):277-81. PubMed ID: 10942172
[TBL] [Abstract][Full Text] [Related]
19. Influence of beta-adrenoceptor blockade on the myocardial accumulation of fatty acid tracer and its intracellular metabolism in the heart after ischemia-reperfusion injury.
Igarashi N; Nozawa T; Fujii N; Suzuki T; Matsuki A; Nakadate T; Igawa A; Inoue H
Circ J; 2006 Nov; 70(11):1509-14. PubMed ID: 17062979
[TBL] [Abstract][Full Text] [Related]
20. Beta-adrenoceptor blocker carvedilol provides cardioprotection via an adenosine-dependent mechanism in ischemic canine hearts.
Asanuma H; Minamino T; Sanada S; Takashima S; Ogita H; Ogai A; Asakura M; Liao Y; Asano Y; Shintani Y; Kim J; Shinozaki Y; Mori H; Node K; Kitamura S; Tomoike H; Hori M; Kitakaze M
Circulation; 2004 Jun; 109(22):2773-9. PubMed ID: 15148268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
